on June 9, 2005
Published online before print June 9, 2005, doi: 10.1161/01.ATV.0000173419.31242.56
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on March 18, 2005
Accepted on June 1, 2005
Regulation of Tissue Factor-Mediated Initiation of the Coagulation Cascade by Cell Surface Grp78
Gourab Bhattacharjee *;
From the Department of Immunology, The Scripps Research Institute, La Jolla, Calif.
* To whom correspondence should be addressed. E-mail: gourab{at}scripps.edu.
Objective--To test the hypothesis that Grp78 negatively regulates cell surface tissue factor (TF) procoagulant activity and whether this is mediated by physical interaction.
Methods and Results--Biopanning with phage-displayed peptidyl libraries has identified peptide probes that bind selectively in vivo to the surface of atherosclerotic plaque endothelium. The highest affinity peptide, EKO130, binds 78-kDa glucose regulated protein (Grp78). Grp78 participates in numerous pathological processes, including the regulation of the coagulation cascade, but the mechanism of Grp78 regulation of coagulation is unknown. To characterize this function, we analyzed the effect of Grp78 on TF-mediated procoagulant activity on murine brain endothelial cells (bEND.3) and macrophage-like (RAW) cells, which are relevant in mediation of atherothrombosis. We show that Grp78 is present on the surface of endothelium and monocyte/macrophage-like cells in atherosclerotic lesions. Inhibition of Grp78 resulted in increased procoagulant activity. We demonstrate that Grp78 negatively regulates procoagulant activity by interacting physically with the TF extracellular domain on the cell surface.
Conclusions--The evidence indicates that Grp78 negatively regulates TF functional activity via direct binding to and functional inhibition of TF. Identification of the mechanism by which Grp78 regulates TF function may advance insight into the pathobiology of atherosclerosis and associated arterial thrombosis.
Key words: atherosclerosis • coagulation • endothelium • Grp78 • thrombosis • ttissue factor
This article has been cited by other articles:
 |
|
 |
|
  F. Schaffner and W. Ruf Tissue Factor and PAR2 Signaling in the Tumor Microenvironment Arterioscler Thromb Vasc Biol, December 1, 2009; 29(12): 1999 - 2004. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. E. Feaver, N. E. Hastings, A. Pryor, and B. R. Blackman GRP78 Upregulation by Atheroprone Shear Stress Via p38-, {alpha}2{beta}1-Dependent Mechanism in Endothelial Cells Arterioscler Thromb Vasc Biol, August 1, 2008; 28(8): 1534 - 1541. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Philippova, D. Ivanov, M. B. Joshi, E. Kyriakakis, K. Rupp, T. Afonyushkin, V. Bochkov, P. Erne, and T. J. Resink Identification of Proteins Associating with Glycosylphosphatidylinositol- Anchored T-Cadherin on the Surface of Vascular Endothelial Cells: Role for Grp78/BiP in T-Cadherin-Dependent Cell Survival Mol. Cell. Biol., June 15, 2008; 28(12): 4004 - 4017. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Luo, C. Mao, B. Lee, and A. S. Lee GRP78/BiP Is Required for Cell Proliferation and Protecting the Inner Cell Mass from Apoptosis during Early Mouse Embryonic Development Mol. Cell. Biol., August 1, 2006; 26(15): 5688 - 5697. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Pozza and R. C. Austin Getting a GRP on Tissue Factor Activation Arterioscler Thromb Vasc Biol, August 1, 2005; 25(8): 1529 - 1531. [Full Text] [PDF]
|
|